type here...

Health Care

Antitrust and Competition

The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in US Health Care Markets

Leemore Dafny
Harvard Business School professor Leemore Dafny lays out potential reforms to assist agencies in halting anticompetitive acquisitions and practices, and to preserve...
Read more
Antitrust and Competition

More Than 20 Years of Consolidation Have Led to a Dysfunctional Health Care Market

Martin Gaynor
The US health care system is based on markets, which do not function as well as they could, or should. Prices are...
Read more
Antitrust and Competition

Invigorating Competition in Health Care Markets: Is Rate Regulation Needed?

Tim Greaney
It now appears that market concentration may be the leading cause of America’s health care cost crisis. If the United States is...
Read more
Antitrust and Competition

Opening the Black Box: The Hidden Costs of Data-Driven Mergers in Health Care

Theodosia Stavroulaki
Vertical data-driven mergers between health insurers and drug suppliers may facilitate health insurers’ efforts to discriminate against vulnerable populations, leaving them without...
Read more
Antitrust and Competition

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Rena Conti, Fiona Scott Morton, Adam Kroetsch, Stephen Colvill, Mark Rosenberg
Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but...
Read more
Antitrust and Competition

How the FTC Protected the Market Power of Pharmacy Benefit Managers

Stacy Mitchell, Zach Freed
Pharmacy Benefit Managers (PBMs) were established in the 1960s to control drug costs but have since morphed into one of the most...
Read more
Antitrust and Competition

What Is the Price of a Prescription Drug?

Robin Feldman
Due to lack of transparency and mystery rebates, which are considered trade secrets, figuring out the price of a prescription drug is...
Read more
Antitrust and Competition

Tech Isn’t the Only Sector Deserving of Antitrust Investigation

Alec Stapp
The House Judiciary Committee’s antitrust report was a missed opportunity. The 450-page report focused solely on digital markets. But what about antitrust...
Read more
Antitrust and Competition

“The Antitrust Doctrine We’ve Seen Over the Last 40 Years Simply Does Not Match the Lived Experience of People”

Asher Schechter
In an interview with ProMarket, investigative journalist David Dayen discusses the toll that monopoly power takes on the lives of ordinary Americans...
Read more
Coronavirus

Webinar: Covid-19 and the US Health Care System

ProMarket writers
Political Economy of Covid-19 Series: Watch a Stigler Center conversation between author, journalist, and former health insurance executive Wendell Potter and Chicago Booth...
Read more
123Page 1 of 3

Latest news

Antitrust and Competition

The New Challenges of Assessing Big Tech’s Impact

Michael Gofman, Zhao Jin
Big Tech firms are facing the biggest wave of antitrust legislation in their history. Academic literature reveals the complexity of possible consequences...
Read more
News

The Metaphysics of Regulatory Capture

Karthik Ramanna
Stiglerian capture and corrosive cultural capture, its left-leaning parallel, are ostensibly symbionts, two attempts at identifying impediments to keeping markets competitive by...
Read more
Capitalisn't

The Aristocracy of Talent: Business Intelligence

Adrian Wooldridge
In the following excerpt from his new book, The Aristocracy of Talent: How Meritocracy Made the Modern World, Adrian Wooldridge traces "how universities...
Read more
Antitrust and Competition

Why Privacy Experts Need a Place at the Antitrust Table

Cristina Caffarra, Johnny Ryan
Antitrust enforcers have tended to stay narrowly “in their lane,” failing to engage with how data is collected and used by digital...
Read more
News

Assessing George Stigler’s Economic Theory of Regulation

Cary Coglianese
Despite its flaws and limitations, Stigler’s seminal article on the theory of economic regulation remains an important piece of scholarship worthy of...
Read more
Economic History Series

“Old Chicago” and Freiburg: Why Ordoliberalism Was No “German Oddity”

Stefan Kolev, Ekkehard A. Köhler
Both the Chicago and Freiburg schools faced systemic fragility as the crucial property of societal orders. It was this fragility that served...
Read more
Commentary

The Many Faces of Stigler’s Theory of Economic Regulation: Interest Group Politics Still Thrives—But Industry Often Comes Second

Richard Epstein
Stigler treats industry groups as the heavyweights in regulatory contests. But surprisingly often groups of farmers and workers knock them for a...
Read more
View All

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.

About Us

Categories

What we are readingAntitrust and CompetitionNewsRegulatory CaptureMediaRent seeking